Pharmaceutical Supply Chain Vision Study
Technology-led Transparency Drives Resiliency
Patients have heightened concerns about the origin, availability, safety, quality and cost of their prescription medications and treatments, and they want reassurance that their medications were not compromised in transit. How can pharmaceutical manufacturers increase supply chain transparency to alleviate consumer concerns?
Download the Pharmaceutical Supply Chain Vision Study: Technology-led Transparency Drives Resiliency and read what’s on the minds of patients and pharmaceutical decision-makers.
Key Highlights from Decision-Makers
 | agree supply chain visibility provides a clear competitive advantage |
 | completely trust the entities within the pharmaceutical supply chain to keep medications safe and uncompromised throughout the supply chain |
 | agree that digital access to supply chain information is an asset |
ZEBRA and the stylized Zebra head are trademarks of Zebra Technologies Corp., registered in many jurisdictions worldwide. All other trademarks are the property of their respective owners. © Zebra Technologies Corp. and/or its affiliates.